CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a specialty pharmaceutical company engaged in development and commercialization of therapeutic products for markets using patented or proprietary formulations and modified drug delivery technology.

$3.79  -0.44 (-10.40%)
As of 06/22/2021 15:59:59 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  
IPO date:  10/02/2014
Outstanding shares:  135,473,947
Average volume:  10,216,314
Market cap:   $499,898,864
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    17322U207
ISIN:        
Sedol:      

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   4.55
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%